ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,959.65
      -0.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Graphite Bio Inc (GRPH)

      7. Graphite Bio Inc (GRPH) News

      GRPH

      Graphite Bio (GRPH)

      Graphite Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GRPH
      DateTimeSourceHeadlineSymbolCompany
      03/28/20228:00AMBusiness WireGraphite Bio Announces Participation in H.C. Wainwright Gene Therapy and Gene Editing Virtual ConferenceNASDAQ:GRPHGraphite Bio Inc
      03/23/20228:00AMBusiness WireGraphite Bio Announces Formation of Scientific Advisory BoardNASDAQ:GRPHGraphite Bio Inc
      03/22/20229:45PMTipRanksRBC Capital Sticks to Their Hold Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
      03/22/20227:47AMTipRanksLeerink Partners Thinks Graphite Bio’s Stock is Going to RecoverNASDAQ:GRPHGraphite Bio Inc
      03/21/20228:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      03/21/20228:25AMBusiness WireGraphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      03/03/20228:00AMBusiness WireGraphite Bio Announces Participation in Upcoming Cowen 42nd Annual Health Care ConferenceNASDAQ:GRPHGraphite Bio Inc
      03/02/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      03/02/20228:00AMBusiness WireGraphite Bio Appoints Alethia Young as Chief Financial OfficerNASDAQ:GRPHGraphite Bio Inc
      02/14/20224:32PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GRPHGraphite Bio Inc
      02/14/20226:21AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRPHGraphite Bio Inc
      02/09/20229:23AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRPHGraphite Bio Inc
      01/27/20228:00AMBusiness WireGraphite Bio Announces Participation in Upcoming Investor ConferencesNASDAQ:GRPHGraphite Bio Inc
      12/20/20211:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      12/11/20219:00AMBusiness WireGraphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH Annual Meeting and ExpositionNASDAQ:GRPHGraphite Bio Inc
      12/07/20218:00AMBusiness WireGraphite Bio to Host Key Opinion Leader Webinar on Gene Correction for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
      11/24/20211:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      11/17/20219:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      11/17/20218:00AMBusiness WireGraphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
      11/16/20214:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      11/10/20214:05PMBusiness WireGraphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      11/04/20219:13AMBusiness WireGraphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and ExpositionNASDAQ:GRPHGraphite Bio Inc
      10/21/20218:00AMBusiness WireGraphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing SummitNASDAQ:GRPHGraphite Bio Inc
      10/15/20216:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      10/12/20211:00PMBusiness WireGraphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National ConventionNASDAQ:GRPHGraphite Bio Inc
      10/12/20219:26AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GRPHGraphite Bio Inc
      10/08/20215:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      10/05/20218:00AMBusiness WireGraphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National ConventionNASDAQ:GRPHGraphite Bio Inc
      08/30/20218:00AMBusiness WireGraphite Bio Announces Participation in Upcoming September Investor ConferencesNASDAQ:GRPHGraphite Bio Inc
      08/12/20214:05PMBusiness WireGraphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GRPH